Thinking of using a compounding pharmacy? What you need to know – Harvard Health
What is a compounding pharmacy? What need do they serve, what are the risks associated with them, and how can you find a legitimate compounding pharmacy?…
What is a compounding pharmacy? What need do they serve, what are the risks associated with them, and how can you find a legitimate compounding pharmacy?…
Discover how digestive enzyme supplements like Lactaid and Beano can help your body process sometimes difficult-to-digest foods like dairy, beans, or certain vegetables….
Discover effective methods to get rid of fleas and reduce the risk of flea-borne diseases. Learn about flea prevention strategies that help protect your home,…
Bringing Radioligand Therapy (RLT) Clinical Trials to Your Fingertips We are uniquely positioned at the heart of Theranostics. We’re dedicated to increasing awareness about Theranostics…
In this conclusive sixth episode of our mini-series on the context of sedentary behavior and physical activity, we recap the importance of understanding thes…
No reports match the provided keyword. As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Leslie…
Zach Klaassen and Zach Reardon delve into the nuances of managing nonmetastatic castration-resistant prostate cancer (nmCRPC) in clinical practice. Dr. Reardon discusses the evolving landscape…
Neeraj Agarwal interviews Marta Garcia de Herreros about presentation on tumor suppressor gene (TSG) signatures in metastatic hormone-sensitive prostate cancer (mHSPC). Dr. Garcia de Herreros…
Duncan Gilbert discusses the PATCH trial, comparing transdermal estradiol with LHRH agonists for androgen suppression in non-metastatic prostate cancer. Dr. Gilbert discusses the trial design,…
Rashid Sayyid and Zachary Klaassen discuss the resurgence of radium-223 in treating metastatic castration-resistant prostate cancer (mCRPC), focusing on the PEACE-3 trial results. The conversation…